CLINICAL_TRIALS
trial_result
· 2019-06-25
Clinical Trial Update: A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study [Phase 3]
Summary
Phase 3 clinical trial update for ALKS 5461 in major depressive disorder; study completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alkermes, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-06-25